BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17205288)

  • 1. Overexpressed platelet integrin alphaIIbbeta3 in a Fechtner syndrome patient uneventfully undergoing adenotomy.
    Sturm A; Speer CP; Grossmann R
    Ann Hematol; 2007 May; 86(5):387-8. PubMed ID: 17205288
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel Pro126His beta propeller mutation in integrin alphaIIb causes Glanzmann thrombasthenia by impairing progression of pro-alphaIIbbeta3 from endoplasmic reticulum to Golgi.
    Shen WZ; Ding QL; Jin PP; Wang XF; Jiang YZ; Li SM; Wang HL
    Blood Cells Mol Dis; 2009; 42(1):44-50. PubMed ID: 18976939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein disulphide isomerase in platelet function.
    Manickam N; Sun X; Li M; Gazitt Y; Essex DW
    Br J Haematol; 2008 Jan; 140(2):223-9. PubMed ID: 18028487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allicin and disulfiram enhance platelet integrin alphaIIbbeta3-fibrinogen binding.
    Manaster Y; Shenkman B; Rosenberg N; Savion N
    Thromb Res; 2009 Sep; 124(4):477-82. PubMed ID: 19632706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced GPIIb/IIIa expression in platelets hyposensitive to catecholamines when activated with TRAP.
    Kim JM; Koo YK; Heo JE; Park S; Yun-Choi HS
    Thromb Res; 2009 May; 124(1):90-5. PubMed ID: 19232685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MgSO
    Scavone M; Bossi E; Podda GM; Cattaneo M
    Br J Haematol; 2021 Mar; 192(6):e144-e148. PubMed ID: 33618427
    [No Abstract]   [Full Text] [Related]  

  • 7. An inherited macrothrombocytopenic disorder with abnormal large granules.
    Wu S; Wang Z; Dai L; Huang R; Wang X; Li S; Bai X; Mao D; Ruan C
    Platelets; 2006 Jun; 17(4):259-65. PubMed ID: 16769603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blockers of platelet glycoprotein IIb/IIIa-receptors in the treatment of patients with acute coronary syndrome and during transcutaneous coronary interventions].
    Fettser DV; Preobrazhenskiĭ DV; Batyraliev TA; Sidorenko BA; Aĭtach V
    Ter Arkh; 2009; 81(1):84-7. PubMed ID: 19253720
    [No Abstract]   [Full Text] [Related]  

  • 9. Reassociation and translocation of glycoprotein IIB-IIIA in EDTA-treated human platelets.
    Ma Y; Wong K
    Platelets; 2007 Sep; 18(6):451-9. PubMed ID: 17763154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor H binds to platelet integrin alphaIIbbeta3.
    Mnjoyan Z; Li J; Afshar-Kharghan V
    Platelets; 2008 Nov; 19(7):512-9. PubMed ID: 18979363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-density lipoprotein specifically binds glycoprotein IIb/IIIa: a flow cytometric method for ligand-receptor interaction.
    Tetik S; Uras F; Ekşioğlu-Demiralp E; Turay Yardimci K
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):210-9. PubMed ID: 18160616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tickling the tails: cytoplasmic domain proteins that regulate integrin alphaIIbbeta3 activation.
    Leisner TM; Yuan W; DeNofrio JC; Liu J; Parise LV
    Curr Opin Hematol; 2007 May; 14(3):255-61. PubMed ID: 17414216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of adaptor protein GIT1 in platelets, leading to the interaction between GIT1 and integrin alpha(IIb)beta3.
    Sato H; Suzuki-Inoue K; Inoue O; Ozaki Y
    Biochem Biophys Res Commun; 2008 Mar; 368(1):157-61. PubMed ID: 18211801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet function in humans is not altered by hyperbaric oxygen therapy.
    Thom SR; Fisher D; Stubbs JM
    Undersea Hyperb Med; 2006; 33(2):81-3. PubMed ID: 16716056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glanzmann's thrombasthenia in North Indians: sub classification and carrier detection by flow cytometry.
    Kannan M; Ahmad F; Yadav BK; Anand M; Jain P; Kumar R; Saxena R
    Platelets; 2009 Feb; 20(1):12-5. PubMed ID: 19172516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic integrin inhibition: allosteric and activation-specific inhibition strategies may surpass the initial ligand-mimetic strategies.
    Ahrens I; Peter K
    Thromb Haemost; 2008 May; 99(5):803-4. PubMed ID: 18449408
    [No Abstract]   [Full Text] [Related]  

  • 17. Sebastian syndrome with abnormal platelet response to ristocetin.
    Redman R; Shunkwiler SM; Harris NS; Kedar A; Clapp WL
    Lab Hematol; 2008; 14(3):19-23. PubMed ID: 18812282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD9 negatively regulates integrin alphaIIbbeta3 activation and could thus prevent excessive platelet recruitment at sites of vascular injury.
    Mangin PH; Kleitz L; Boucheix C; Gachet C; Lanza F
    J Thromb Haemost; 2009 May; 7(5):900-2. PubMed ID: 19228283
    [No Abstract]   [Full Text] [Related]  

  • 19. A beta3 Asp217-->Val substitution in a patient with variant Glanzmann Thrombasthenia severely affects integrin alphaIIBbeta3 functions.
    D'Andrea G; Bafunno V; Del Vecchio L; Amoriello A; Morabito P; Vecchione G; Grandone E; Margaglione M
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):657-62. PubMed ID: 18832906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compartmentalization regulates the interaction between the platelet integrin alpha IIb beta 3 and ICln.
    Larkin D; Treumann A; Murphy D; DeChaumont C; Kiernan A; Moran N
    Br J Haematol; 2009 Feb; 144(4):580-90. PubMed ID: 19055659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.